Amidst this COVID-19 Pandemic where every researcher is busy finding an antidote for COVID-19, Beijing-based pharmaceutical company shows a ray of hope. The National Biotec Group of Beijing has cleared final trials for COVID-19 shot testing. Previously, first and second shots were tested on 1000 Chinese Nationals. Shot 2 was found effective whose data is to be revealed on June 28.
As the coronavirus cases in China has reduced to around 350, Chinese Scientists are facing difficulties in conducting vaccination trials. For that, they are mostly depending on Middle-East Countries such as the United Arab Emirates. The UAE is still facing around 100 cases per day and after all the tests are done and results seen, UAE Administration has approved the Chinese Pharma Company to conduct its final testing in UAE.
On March 11, the World Health Organization declared COVID-19 as a Worldwide Pandemic. Since then, several nations have implemented lockdowns for a month or more. Till now, around 9.5 million people have been affected and around 475,000 people have lost their lives.
In this rat race of developing the vaccine, CNBG is the first Pharmaceutical Company that has passed to reach Phase-III trials in coronavirus vaccine shots. CNBG along with Abu Dhabi based firm G42 will be carrying out final trials for this vaccine. However, CNBG has not disclosed an inch of their planning which includes the number of clinical testers, location of testing, and mid-results.
The condition of India is worsening day by day with around 16,000-17,000 confirmed cases per day. On a more positive note, the recovery rate is also increasing, around 9000-10000 patients daily. In this crisis, if the vaccine goes for final trials and passes, it will be a great relief for mankind.
Till now, the USA has the worst scenario with 2.45 Million Patients and 130,000 deaths. Followed by Brazil with 1.5 Million Cases. India is standing at number four just after Russia with 470,000 cases nationwide. India has a total recovery rate of around 56.3%.
Novel Coronavirus has claimed many lives and has caused a severe downfall in the economy, due to which, many families have lost their sources of income. Prices of daily commodities are immensely hiked due to shortage of supply. Many Pharmaceutical companies are busy in finding a cure for it. In this crisis, let’s hope for the best. Whosoever finds the cure first, should do it for Humanity.
- Debraj for India Against COVID
As the coronavirus cases in China has reduced to around 350, Chinese Scientists are facing difficulties in conducting vaccination trials. For that, they are mostly depending on Middle-East Countries such as the United Arab Emirates. The UAE is still facing around 100 cases per day and after all the tests are done and results seen, UAE Administration has approved the Chinese Pharma Company to conduct its final testing in UAE.
On March 11, the World Health Organization declared COVID-19 as a Worldwide Pandemic. Since then, several nations have implemented lockdowns for a month or more. Till now, around 9.5 million people have been affected and around 475,000 people have lost their lives.
In this rat race of developing the vaccine, CNBG is the first Pharmaceutical Company that has passed to reach Phase-III trials in coronavirus vaccine shots. CNBG along with Abu Dhabi based firm G42 will be carrying out final trials for this vaccine. However, CNBG has not disclosed an inch of their planning which includes the number of clinical testers, location of testing, and mid-results.
The condition of India is worsening day by day with around 16,000-17,000 confirmed cases per day. On a more positive note, the recovery rate is also increasing, around 9000-10000 patients daily. In this crisis, if the vaccine goes for final trials and passes, it will be a great relief for mankind.
Till now, the USA has the worst scenario with 2.45 Million Patients and 130,000 deaths. Followed by Brazil with 1.5 Million Cases. India is standing at number four just after Russia with 470,000 cases nationwide. India has a total recovery rate of around 56.3%.
Novel Coronavirus has claimed many lives and has caused a severe downfall in the economy, due to which, many families have lost their sources of income. Prices of daily commodities are immensely hiked due to shortage of supply. Many Pharmaceutical companies are busy in finding a cure for it. In this crisis, let’s hope for the best. Whosoever finds the cure first, should do it for Humanity.
- Debraj for India Against COVID
Very Informative blog... Get learn a lot of things...
ReplyDelete